Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Zhang, Wei ^a   Qiao, Haishi ^a   Lv, Yuanzi ^a   Wang, Jingjing ^a   Chen, Xiaoqing ^a   Hou, Yayi ^a   Tan, Renxiang ^a   Li, Erguang ^a,b  

^a NANJING UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; GREEN FLUORESCENT PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; KAEMPFEROL; TRANS ACTING FACTOR; UNCLASSIFIED DRUG; VIRUS RNA; HNRNP A1; INTERNAL RIBOSOME ENTRY SITE; SMALL INTERFERING RNA;

5' UNTRANSLATED REGION; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; EC50; ENTEROVIRUS 71; ENTEROVIRUS 71 INFECTION; ENTEROVIRUS INFECTION; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; PLASMID; PROTEIN EXPRESSION; RHABDOMYOSARCOMA CELL; VERO CELL LINE; VIRUS TRANSCRIPTION; WESTERN BLOTTING; DRUG EFFECTS; ENTEROVIRUS A; ENTEROVIRUS INFECTIONS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOGENICITY; PATHOLOGY; PROTEIN SYNTHESIS; VIRION; VIROLOGY; VIRUS REPLICATION;

HUMAN ENTEROVIRUS 71;

APIGENIN; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; INTERNAL RIBOSOME ENTRY SITES; PROTEIN BIOSYNTHESIS; RNA, SMALL INTERFERING; RNA, VIRAL; VIRION; VIRUS REPLICATION;

EID: 84908032034     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110429     Document Type: Article

References (31)

1. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, et al. (2010) Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10: 778-790.
2. Yang F, Ren L, Xiong Z, Li J, Xiao Y, et al. (2009) Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol 47: 2351-2352.
3. Kuo RL, Shih SR (2013) Strategies to develop antivirals against enterovirus 71. Virol J 10: 28.
4. Thompson SR, Sarnow P (2003) Enterovirus 71 contains a type I IRES element that functions when eukaryotic initiation factor eIF4G is cleaved. Virology 315: 259-266.
5. Junemann C, Song Y, Bassili G, Goergen D, Henke J, et al. (2007) Picornavirus internal ribosome entry site elements can stimulate translation of upstream genes. J Biol Chem 282: 132-141.
6. Shih SR, Stollar V, Li ML (2011) Host factors in enterovirus 71 replication. J Virol 85: 9658-9666.
7. Lin JY, Shih SR, Pan M, Li C, Lue CF, et al. (2009) hnRNP A1 interacts with the 5′ untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J Virol 83: 6106-6114.
8. Chen LL, Kung YA, Weng KF, Lin JY, Horng JT, et al. (2013) Enterovirus 71 infection cleaves a negative regulator for viral internal ribosomal entry site-driven translation. J Virol 87: 3828-3838.
9. Lin JY, Li ML, Huang PN, Chien KY, Horng JT, et al. (2008) Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5′ untranslated region and participates in virus replication. J Gen Virol 89: 2540-2549.
10. Levengood JD, Tolbert M, Li ML, Tolbert BS (2013) High-affinity interaction of hnRNP A1 with conserved RNA structural elements is required for translation and replication of enterovirus 71. RNA Biol 10: 1136-1145.
11. Tsai FJ, Lin CW, Lai CC, Lan YC, Lai CH, et al. (2011) Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins. Food Chem 128: 312-322.
12. Jean-Philippe J, Paz S, Caputi M (2013) hnRNP A1: the Swiss army knife of gene expression. Int J Mol Sci 14: 18999-19024.
13. Singh RK, Cooper TA (2012) Pre-mRNA splicing in disease and therapeutics. Trends Mol Med 18: 472-482.
14. Zhang J, Manley JL (2013) Misregulation of pre-mRNA alternative splicing in cancer. Cancer Discov 3: 1228-1237.
15. Bekenstein U, Soreq H (2013) Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles. Mol Cell Neurosci 56: 436-446.
16. Lo CS, Chang SY, Chenier I, Filep JG, Ingelfinger JR, et al. (2012) Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice. Diabetes 61: 2597-2608.
17. Arango D, Morohashi K, Yilmaz A, Kuramochi K, Parihar A, et al. (2013) Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets. Proc Natl Acad Sci U S A 110: E2153-2162.
18. Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27: 493-497.
19. Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco MA (2002) Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods 26: 182-190.
20. Li ZH, Li CM, Ling P, Shen FH, Chen SH, et al. (2008) Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis 197: 854-857.
21. Biamonti G, Ruggiu M, Saccone S, Della Valle G, Riva S (1994) Two homologous genes, originated by duplication, encode the human hnRNP proteins A2 and A1. Nucleic Acids Res 22: 1996-2002.
22. Dreyfuss G, Kim VN, Kataoka N (2002) Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 3: 195-205.
23. Brown BA, Pallansch MA (1995) Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 39: 195-205.
24. Siafakas N, Markoulatos P, Stanway G (2002) Variability in molecular typing of Coxsackie A viruses by RFLP analysis and sequencing. J Clin Lab Anal 16: 59-69.
25. Yeh MT, Wang SW, Yu CK, Lin KH, Lei HY, et al. (2011) A single nucleotide in stem loop II of 5′-untranslated region contributes to virulence of enterovirus 71 in mice. PLoS One 6: e27082.
26. Manthey JA, Grohmann K, Guthrie N (2001) Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem 8: 135-153.
27. Orhan DD, Ozcelik B, Ozgen S, Ergun F (2010) Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol Res 165: 496-504.
28. Kumar S, Pandey AK (2013) Chemistry and biological activities of flavonoids: an overview. The Scientific World Journal 2013: 162750.
29. Conti C, Genovese D, Santoro R, Stein ML, Orsi N, et al. (1990) Activities and mechanisms of action of halogen-substituted flavanoids against poliovirus type 2 infection in vitro. Antimicrob Agents Chemother 34: 460-466.
30. Superti F, Seganti L, Orsi N, Divizia M, Gabrieli R, et al. (1989) Effect of isoflavans and isoflavenes on the infection of Frp/3 cells by hepatitis A virus. Antiviral Res 11: 247-254.
31. Tait S, Salvati AL, Desideri N, Fiore L (2006) Antiviral activity of substituted homoisoflavonoids on enteroviruses. Antiviral Res 72: 252-255.